These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

92 related items for PubMed ID: 23867685

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Treatment of endocarditis due to Proteus species: a literature review.
    Kalra A, Cooley C, Tsigrelis C.
    Int J Infect Dis; 2011 Apr; 15(4):e222-5. PubMed ID: 21237686
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Prevalence of Proteus species in urinary tract infections.
    Shriniwas, Biswas TD.
    Indian J Med Res; 1986 Aug; 84():148-54. PubMed ID: 3759166
    [No Abstract] [Full Text] [Related]

  • 10. Emergence of Proteus mirabilis carrying the bla metallo-beta-lactamase gene.
    Vourli S, Tsorlini H, Katsifa H, Polemis M, Tzouvelekis LS, Kontodimou A, Vatopoulos AC.
    Clin Microbiol Infect; 2006 Jul; 12(7):691-4. PubMed ID: 16774572
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Proteus mirabilis bloodstream infections: risk factors and treatment outcome related to the expression of extended-spectrum beta-lactamases.
    Endimiani A, Luzzaro F, Brigante G, Perilli M, Lombardi G, Amicosante G, Rossolini GM, Toniolo A.
    Antimicrob Agents Chemother; 2005 Jul; 49(7):2598-605. PubMed ID: 15980325
    [Abstract] [Full Text] [Related]

  • 16. [Use of benzylpenicillin in the treatment of Proteus infections].
    Fomina IP, Sorokina MI, Kuznetsova SM, Lobuseva AN, Navashin SM.
    Antibiotiki; 1971 May; 16(5):450-4. PubMed ID: 5210806
    [No Abstract] [Full Text] [Related]

  • 17. Salmonella enterica subsp. enterica producing VIM-1 carbapenemase isolated from livestock farms.
    Fischer J, Rodríguez I, Schmoger S, Friese A, Roesler U, Helmuth R, Guerra B.
    J Antimicrob Chemother; 2013 Feb; 68(2):478-80. PubMed ID: 23034713
    [No Abstract] [Full Text] [Related]

  • 18. Cefotaximase and AmpC-producing Shigella flexneri in case of dysentery from southern India.
    Oommen S, Pillai PM, Sushamabai S, Paul PJ.
    Indian J Med Microbiol; 2013 Feb; 31(1):77-9. PubMed ID: 23508436
    [Abstract] [Full Text] [Related]

  • 19. The first detection of CTX-M-14 extended-spectrum beta-lactamase among diverse beta-lactamase-producing Proteus mirabilis clinical isolates.
    Yong D, Lim YS, Roh KH, Choi YS, Park DY, Yum JH, Kim JM, Lee K, Chong Y.
    Diagn Microbiol Infect Dis; 2006 Mar; 54(3):237-9. PubMed ID: 16427241
    [Abstract] [Full Text] [Related]

  • 20. Pseudomonas aeruginosa and proteus infections in premature babies and in infants. Therapeutic trial with carbenicillin.
    Korányi G, Pesti E, Somogyi G.
    Acta Paediatr Acad Sci Hung; 1970 Mar; 11(2):141-50. PubMed ID: 4994152
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.